Further, because TRPM1 was shown to exhibit tumor suppressor properties [4], decreased expression may serve as a biomarker for the development of a highly differentiated, aggressive form of melanoma since TRPM1 concentrations consistently decrease with the progression of the disease [3]. The gene discussed is TRPM1; the disease is melanoma.